A prospective observational study of obesity, body composition, and insulin resistance in 18 women with bipolar disorder and 17 matched control subjects

Journal of Clinical Psychiatry

Volumn 69, Issue 12, 2008, Pages 1892-1900

  Fleet Michaliszyn, Sara B ^a   Soreca, Isabella ^b   Otto, Amy D ^c   Jakicic, John M ^c   Fagiolini, Andrea ^b   Kupfer, David J ^b   Goodpaster, Bret H ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL FAT; ABDOMINAL OBESITY; ADULT; ARTICLE; BIPOLAR DISORDER; BLOOD PRESSURE; BODY COMPOSITION; CALORIMETRY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIETARY INTAKE; ENERGY BALANCE; ENERGY EXPENDITURE; FEMALE; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID BLOOD LEVEL; LIPID OXIDATION; METABOLIC RATE; OBESITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK FACTOR;

ADULT; BIPOLAR DISORDER; BODY COMPOSITION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COMORBIDITY; ENERGY METABOLISM; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK FACTORS; WAIST-HIP RATIO;

EID: 60349126636     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n1207     Document Type: Article

References (50)

1. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003 Jan;289(1):76-79
2. al-Isa AN. Prevalence of obesity among adult Kuwaitis: a cross-sectional study. Int J Obes Relat Metab Disord 1995 Jun;19(6):431-433
3. Arroyo P, Loria A, Fernandez V, et al. Prevalence of pre-obesity and obesity in urban adult Mexicans in comparison with other large surveys. Obes Res 2000 Mar;8(2):179-185
4. Flegal KM, Carroll MD, Kuczmarski RJ, et al. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 1998 Jan;22(1):39-47
5. Hernandez RE, Cardonnet LJ, Libman C, et al. Prevalence of diabetes and obesity in an urban population of Argentina. Diabetes Res Clin Pract 1987 Sep-Oct;3(5):277-283
6. Hodge AM, Dowse GK, Zimmet PZ, et al. Prevalence and secular trends in obesity in Pacific and Indian Ocean island populations. Obes Res 1995 Sep;3(suppl 2):77S-87S
7. Elmslie JL, Silverstone JT, Mann JI, et al. Prevalence of overweight and obesity in bipolar patients. J Clin Psychiatry 2000 Mar;61(3):179-184
8. Fagiolini A, Frank E, Houck PR, et al. Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. J Clin Psychiatry 2002 Jun;63(6):528-533
9. Fagiolini A, Kupfer DJ, Houck PR, et al. Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry 2003 Jan; 160(1):112-117
10. McElroy SL, Frye MA, Suppes T, et al. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry 2002 Mar;63(3):207-213
11. McElroy SL, Kotwal R, Malhotra S, et al. Are mood disorders and obesity related? a review for the mental health professional. J Clin Psychiatry 2004 May;65(5):634-651
12. Tirupati S, Chua LE. Obesity and metabolic syndrome in a psychiatric rehabilitation service. Aust N Z J Psychiatry 2007 Jul;41(7):606-610
13. Cassidy F, Ahearn E, Carroll BJ. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry 1999 Sep; 156(9):1417-1420
14. Lilliker SL. Prevalence of diabetes in a manic-depressive population. Compr Psychiatry 1980 Jul-Aug;21(4):270-275
15. Regenold WT, Thapar RK, Marano C, et al. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord 2002 Jun;70(1):19-26
16. Russell JD, Johnson GF. Affective disorders, diabetes mellitus and lithium. Aust N Z J Psychiatry 1981 Dec;15(4):349-353
17. Atmaca M, Kuloglu M, Tezcan E, et al. Serum leptin and cholesterol values in suicide attempters. Neuropsychobiology 2002;45(3):124-127
18. Yates WR, Wallace R. Cardiovascular risk factors in affective disorder. J Affect Disord 1987 Mar-Apr;12(2):129-134
19. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002 Dec;288(21):2709-2716
20. Reilly MP, Rader DJ. The metabolic syndrome: more than the sum of its parts? Circulation 2003 Sep;108(13):1546-1551
21. Haffner SM. Impaired glucose tolerance, insulin resistance and cardiovascular disease. Diabet Med 1997 Aug;14(suppl 3):S12-S18
22. Lempiainen P, Mykkanen L, Pyorala K, et al. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 1999 Jul;100(2):123-128
23. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1988 Dec;37(12):1595-1607
24. Goodpaster BH, Thaete FL, Simoneau JA, et al. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997 Oct;46(10):1579-1585
25. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev 1994 Oct;74(4):761-811
26. Ravussin E, Lillioja S, Knowler WC, et al. Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med 1988 Feb;318(8):467-472
27. Kelley DE, Goodpaster B, Wing RR, et al. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 1999 Dec;277(6 Pt 1):E1130-E1141
28. Wirshing DA, Wirshing WC, Kysar L, et al. Novel antipsychotics: comparison of weight gain liabilities. J Clin Psychiatry 1999 Jun;60(6):358-363
29. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P, Version 2.0). New York, NY: Biometrics Research, New York State Psychiatric Institute; 1995:
30. Block G, Hartman AM, Dresser CM, et al. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986 Sep;124(3):453-469
31. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 Jul;28(7):412-419
32. Hermans MP, Levy JC, Morris RJ, et al. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia 1999 Jun;42(6):678-687
33. Isbell TR, Klesges RC, Meyers AW, et al. Measurement reliability and reactivity using repeated measurements of resting energy expenditure with a face mask, mouthpiece, and ventilated canopy. JPEN J Parenter Enteral Nutr 1991 Mar-Apr;15(2):165-168
34. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 1983 Aug;55(2):628-634
35. St-Onge M, Mignault D, Allison DB, et al. Evaluation of a portable device to measure daily energy expenditure in free-living adults. Am J Clin Nutr 2007 Mar;85(3):742-749
36. Mullen BJ, Krantzler NJ, Grivetti LE, et al. Validity of a food frequency questionnaire for the determination of individual food intake. Am J Clin Nutr 1984 Jan;39(1):136-143
37. Metz JA, Karanja N, Torok J, et al. Modification of total body fat in spontaneously hypertensive rats and Wistar-Kyoto rats by dietary calcium and sodium. Am J Hypertens 1988 Jan;1(1):58-60
38. Fagiolini A, Kupfer DJ. Is treatment-resistant depression a unique subtype of depression? Biol Psychiatry 2003 Apr;53(8):640-648
39. el-Dakhakhny M, Abdel el-Latif HA, Ammon HP. Different effects of the antidepressant drugs imipramine, maprotiline and bupropion on insulin secretion from mouse pancreatic islets. Arzneimittelforschung 1996 Jul;46(7):667-669
40. Erenmemisoglu A, Ozdogan UK, Saraymen R, et al. Effect of some antidepressants on glycaemia and insulin levels of normoglycaemic and alloxan-induced hyperglycaemic mice. J Pharm Pharmacol 1999 Jun; 51(6):741-743
41. McIntyre RS, Soczynska JK, Konarski JZ, et al. The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Expert Opin Drug Saf 2006 Jan;5(1):157-168
42. Jensen MD, Kanaley JA, Reed JE, et al. Measurement of abdominal and visceral fat with computed tomography and dual-energy x-ray absorptiometry. Am J Clin Nutr 1995 Feb;61(2):274-278
43. Fagiolini A, Frank E, Cherry CR, et al. Clinical indicators for the use of antidepressants in the treatment of bipolar I depression. Bipolar Disord 2002 Oct;4(5):277-282
44. Colditz GA, Willett WC, Rotnitzky A, et al. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995 Apr;122(7):481-486
45. Carey DG, Jenkins AB, Campbell LV, et al. Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 1996 May;45(5):633-638
46. Brochu M, Tchernof A, Dionne IJ, et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 2001 Mar;86(3):1020-1025
47. Zurlo F, Lillioja S, Esposito-Del Puente A, et al. Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol 1990 Nov;259(5 Pt 1):E650-E657
48. Elmslie JL, Mann JI, Silverstone JT, et al. Determinants of overweight and obesity in patients with bipolar disorder. J Clin Psychiatry 2001 Jun;62(6):486-491
49. Davidson S, Judd F, Jolley D, et al. Cardiovascular risk factors for people with mental illness. Aust N Z J Psychiatry 2001 Apr;35(2):196-202
50. Australian National Heart Foundation. The Risk Factor Prevalence Survey. Canberra: Australian Institute of Health and Welfare; 1989